Atlassian Announces Second Quarter Fiscal Year 2018 Results
Jan 18, 2018 21:05 pm UTC| Business
Quarterly revenue of $212.6 million, up 43% year-over-year Quarterly IFRS operating margin of (7%) and non-IFRS operating margin of 21% Quarterly free cash flow of $67.8 million SAN FRANCISCO, Jan. 18, 2018 --...
Jan 18, 2018 21:05 pm UTC| Business
AUSTIN, Texas, Jan. 18, 2018 -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a biotechnology company committed to the discovery and development of engineered human enzyme therapeutics for patients with rare genetic...
Jan 18, 2018 21:05 pm UTC| Business
Transaction and Partnership Highlights The transaction brings together GWG Holdings (GWGH), a leading innovator in the life insurance industry, and The Beneficient Company Group, L.P. (BEN), designed to be one of the...
Web.com Announces Date of Fourth Quarter 2017 Conference Call and Webcast
Jan 18, 2018 21:05 pm UTC| Business
JACKSONVILLE, Fla., Jan. 18, 2018 -- Web.com Group, Inc. (Nasdaq:WEB), a leading provider of Internet services and online marketing solutions for small businesses, today announced it will report its fourth quarter...
MINDBODY to Report Fourth Quarter and Full Year 2017 Financial Results on February 21, 2018
Jan 18, 2018 21:05 pm UTC| Business
SAN LUIS OBISPO, Calif., Jan. 18, 2018 -- MINDBODY (NASDAQ:MB), the leading technology platform for the wellness services industry, today announced that it will issue its financial results for the fourth quarter ended...
Tuesday Morning Corporation Announces Reporting Date for Second Quarter Fiscal 2018 Results
Jan 18, 2018 21:05 pm UTC| Business
DALLAS, Jan. 18, 2018 -- Tuesday Morning Corporation (NASDAQ:TUES), today announced that the Company will hold a conference call to discuss its second quarter fiscal 2018 financial results and provide a general business...
TRACON Pharmaceuticals Reports Granting of Inducement Awards
Jan 18, 2018 21:05 pm UTC| Business
SAN DIEGO, Jan. 18, 2018 -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related...